Senate Confirms Dr. Erica Schwartz as CDC Director

Dr. Erica Schwartz was confirmed by the U.S. Senate as director of the Centers for Disease Control and Prevention (CDC) on August 5, 2026, becoming the agency's first permanent leader in more than a year and its 22nd director if counting historical succession. She was President Trump's nominee for the post, following earlier failed attempts by the administration to fill senior health leadership positions. Senator Bill Cassidy, considered a key swing vote on the Senate health committee, had withheld public support for days before ultimately backing her nomination. Schwartz's nomination advanced out of the Senate health committee on July 30, 2026, before proceeding to a full Senate floor vote. The Senate confirmed her by a vote of 51-44, with the tally breaking largely along party lines; Senator Tim Kaine of Virginia was the sole Democrat to vote in favor of her confirmation. During the confirmation process, some senators and observers raised concerns about whether Schwartz would be able to resist political pressure in her role, including questions about her independence from Health and Human Services Secretary Robert F. Kennedy Jr. on vaccine policy. Schwartz has now assumed leadership of the CDC, ending a period of more than a year without a permanent director at the agency. Reports diverge on emphasis: some coverage frames the confirmation as a rare administration success after previous stalled health nominations, while other reporting focuses on unresolved concerns about her ability to maintain scientific independence amid political pressures. One report also referenced a diarrhea-causing parasite outbreak in the U.S. as contextual backdrop to her confirmation, though details of that outbreak were not corroborated across multiple sources and remain unverified in this set of reporting.